Chemistry:Nifurzide

Nifurzide
Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	A07AX04 (WHO) ;
Identifiers
	IUPAC name 5-Nitro-N′-[(1E,2E)-3-(5-nitro-2-furyl)-2-propen-1-ylidene]-2-thiophenecarbohydrazide;
CAS Number	39978-42-2 ;
PubChem CID	9571044;
ChemSpider	7845510;
UNII	Z35R6K4C26;
KEGG	D07251 ;
Chemical and physical data
Formula	C12H8N4O6S
Molar mass	336.28 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES [O-][N+](=O)c1ccc(o1)/C=C/C=N/NC(=O)c2ccc(s2)[N+](=O)[O-];
	InChI InChI=1S/C12H8N4O6S/c17-12(9-4-6-11(23-9)16(20)21)14-13-7-1-2-8-3-5-10(22-8)15(18)19/h1-7H,(H,14,17)/b2-1+,13-7+; Key:IDUMOVRJNBNOTR-BIZLIJPVSA-N;
	(verify)

Short description: Chemical compound

Nifurzide is a nitrofuran derivative and intestinal anti-infectious agent active against Escherichia coli.^[1]

References

0.00

(0 votes)

Original source: https://en.wikipedia.org/wiki/Nifurzide. Read more

v t e Antidiarrheals, intestinal anti-inflammatory and anti-infective agents (A07)
Rehydration	Oral rehydration therapy
Intestinal anti-infectives	Antibiotics Amphotericin B Colistin Fidaxomicin Kanamycin Natamycin Neomycin Nystatin Paromomycin Polymyxin B Rifaximin Streptomycin Vancomycin Sulfonamides Phthalylsulfathiazole Succinylsulfathiazole Sulfaguanidine Nitrofuran Nifuroxazide Nifurzide Imidazole Miconazole Arsenical Acetarsol Oxyquinoline Broxyquinoline
Intestinal adsorbents	Charcoal Bismuth Pectin Kaolin Crospovidone Attapulgite Diosmectite
Antipropulsives (opioids)	Opium tincture (laudanum) Codeine Morphine Camphorated opium tincture (paregoric) crosses BBB: Diphenoxylate (Diphenoxylate/atropine) Difenoxin does not cross BBB: Eluxadoline Loperamide^#
Intestinal anti-inflammatory agents	corticosteroids acting locally Prednisolone^# Hydrocortisone Prednisone Betamethasone^# Tixocortol Budesonide Beclometasone antiallergic agents, excluding corticosteroids Cromoglicic acid Aminosalicylates Sulfasalazine Mesalazine Olsalazine Balsalazide
Antidiarrheal micro-organisms	Saccharomyces boulardii
Other antidiarrheals	Albumin tannate Ceratonia Crofelemer Octreotide Racecadotril
^#WHO-EM ^‡Withdrawn from market Clinical trials: ^†Phase III ^§Never to phase III